Title : Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer.

Pub. Date : 2020

PMID : 33193386






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Murine and human invariant natural killer T (iNKT) lymphocytes are activated by alpha-galactosylceramide (alpha-GalCer) presented on CD1d. alpha-galactosylceramide CD1d molecule Homo sapiens
2 Murine and human invariant natural killer T (iNKT) lymphocytes are activated by alpha-galactosylceramide (alpha-GalCer) presented on CD1d. alpha-galactosylceramide CD1d molecule Homo sapiens